Plasmodium vivax merozoite surface protein 8 cloning, expression, and characterisation

Area of Science:

• Malariology
• Parasitology
• Vaccinology

Background:

• Plasmodium vivax is a widespread malaria parasite causing millions of infections annually, particularly in Asia and Latin America.
• Developing effective vaccines against P. vivax remains a global health priority due to its prevalence and impact.

Purpose of the Study:

• To identify and characterize novel antigens of Plasmodium vivax for vaccine development.
• To evaluate the potential of a newly identified P. vivax merozoite surface protein homologue (PvMSP8) as a vaccine candidate.

Main Methods:

• Genome screening to identify the P. vivax homologue of Plasmodium falciparum merozoite surface protein 8.
• Analysis of protein structure, including epidermal growth factor-like domains and anchor sites.
• Assessment of gene transcription, protein expression, and recognition by patient sera.

Main Results:

• Identification of an open reading frame encoding PvMSP8, a 487-amino acid protein.
• PvMSP8 possesses structural features typical of surface proteins, including signal peptide and GPI anchor sites.
• The gene is transcribed, the protein is expressed, and it is recognized by sera from P. vivax-infected patients.

Conclusions:

• PvMSP8 is a potential candidate antigen for a P. vivax vaccine.
• Its recognition by patient sera and protective immunity observed with homologous proteins in mice support its inclusion in a multi-stage, multi-antigen vaccine strategy.